Loading...
Market
Will a new paper be published in The Lancet about CAR-T cell therapy for children with autoimmune diseases by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Publications in The Lancet
Story
First CAR-T Cell Therapy for 15-Year-Old with Lupus in Germany Shows Promising Results
Jul 11, 2024, 02:36 PM
The world's first CAR-T cell therapy for a child with lupus has shown promising results. A 15-year-old teen from Universitätsklinikum Erlangen in Germany received the treatment in 2023 and reported feeling as good as before the diagnosis, with only a few colds. Previously, CAR-T cells had been used primarily for leukemia, lymphoma, and in studies on adults with advanced autoimmune diseases. This marks the first time the therapy has been used for treating children with autoimmune conditions. The findings were published in a new paper in The Lancet. The breakthrough was highlighted by NatureBiotech and acknowledged by BertrandBio.
View original story
Similar markets
Yes • 50%
No • 50%
Positive results • 25%
Negative results • 25%
Inconclusive results • 25%
Trial halted • 25%
New England Journal of Medicine • 25%
Journal of the American Medical Association • 25%
The Lancet • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Mild side effects • 25%
Moderate side effects • 25%
Severe side effects • 25%
No major side effects • 25%
Improved efficacy • 25%
Reduced side effects • 25%
Lower cost of treatment • 25%
Other • 25%
Yes • 50%
No • 50%
The New England Journal of Medicine • 25%
The Lancet • 25%
JAMA • 25%
Other • 25%
